Multi-analyte Blood Test Clinical Trial

RecruitingOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

March 31, 2025

Conditions
Liver CirrhosisLiver CancerHCCHepatocellular Carcinoma
Interventions
DIAGNOSTIC_TEST

Multi-analyte Blood Test

A clinical diagnostic test based upon the detection and quantification of DNA methylation markers in cell-free DNA (cfDNA) isolated from plasma and of tumor-specific proteins isolated from serum.

Trial Locations (7)

21202

RECRUITING

GI Research Mercy Medical Center, Baltimore

23502

RECRUITING

Digestive & Liver Disease Specialist, Norfolk

33614

RECRUITING

Guardian Angel Research Center, Tampa

76710

RECRUITING

Impact Research Institute, Waco

78539

RECRUITING

South Texas Research Institute, Edinburg

79936

RECRUITING

Texas Gastro Research, El Paso

91345

RECRUITING

Providence Facey Medical Foundation, Mission Hills

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Helio Genomics

INDUSTRY